English (UK)
中文版yanfei zhou
ZhongXi Capital focus on biomedical investment，fiancing，consulting and other capital market business.
ZhongXi Capital
高级投资经理Ivy Zhou
Shenzhen Beimei Pharma is focused in the field of pediatric prescription drugs, and aims to become a new-styled pharmaceutical company integrated with R&D, in-licensing, production and sales. It takes independent R&D and the in-licensing of domestic and international pediatric products as its strategic direction. The current product pipeline covers the respiratory, anti-infection (antibacterial), neuroscience, gastroenterology and others. Beimei Pharma is committed to providing Chinese pediatric patients with convenient, accurate, excellent-taste and high-quality products.
Shenzhen Beimei Pharmaceutical Co. Ltd.
Head of Business DevelopmentMonica Zhou
Established in Shenzhen Special Economic Zone in 1992;
Core competitiveness - A specialty company in digestion and intestinal microecology and a national level Hi-tech Enterprise.
Core competitiveness - A specialty company in digestion and intestinal microecology and a national level Hi-tech Enterprise.
Shenzhen Wanhe Pharma
BDDr. Bin Zhu
Simcere Pharmaceutical Group is a leading Chinese pharmaceutical company with full capability in discovery, development, manufacturing and commercialization. Simcere is actively looking for innovative drug candidates in multiple therapeutic areas. Simcere of America is a subsidiary of Simcere Pharmaceutical Group.
Responsive Web Design powered by 